Showing 2431-2440 of 6373 results for "".
“Do you know how much this white cream costs?”
https://practicaldermatology.com/topics/practice-management/do-you-know-how-much-this-white-cream-costs/21077/Process Control: How Chris' Cafe Relates to Medical Practice
https://practicaldermatology.com/topics/practice-management/process-control-how-chris-cafe-relates-to-medical-practice/21122/Prevention Efforts: Where We Stand
https://practicaldermatology.com/topics/practice-management/prevention-efforts-where-we-stand/21149/EHR User Series: The Search for EHR Mobility
https://practicaldermatology.com/topics/practice-management/ehr-user-series-the-search-for-ehr-mobility/21225/In the electronic age, a truly mobile EHR may be key in the pursuit of fast, efficient medical care.The Price of a Penalty: Unraveling CMS's Latest Moves
https://practicaldermatology.com/topics/practice-management/the-price-of-a-penalty-unraveling-cmss-latest-moves/21435/State Legislation of EHRs: A Sweeping Precedent?
https://practicaldermatology.com/topics/practice-management/state-ehr-legislation-a-new-precedent/21483/A new law in Massachusetts requires all licensed physicians to be using an EHR by 2015.Financial Benchmarking Update for Dermatology Practices
https://practicaldermatology.com/topics/practice-management/financial-benchmarking-update-for-dermatology-practices/21621/Successful practices use benchmarking to compare their performance to others, assess their own performance over time, and plan for the long term.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21848/Dermatology Q&A: Treating Melasma and Photoaging Without Hydroquinone
https://practicaldermatology.com/topics/general-topics/dermatology-qa-treating-melasma-and-photoaging-without-hydroquinone/21867/A recently unveiled skin brightening cream may signal a new direction in the treatment and prevention of pigmentation disorders.Biologics and Beyond
https://practicaldermatology.com/topics/psoriasis/biologics-and-beyond/23554/A look at off-label use of biologics and JAK inhibitors.